NBTX Competitors & Alternatives
Compare Nanobiotix with similar stocks in the same industry
Biotechnology
NBTX
Main Stock$37.01
Tradestie Score
46
Market Cap
$903.54M
Revenue Growth
1.9%
Analyst Upside
+22.3%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$20.45
|
$2.02B | - | 34 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.74
|
$2.01B | - | 32 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$33.41
|
$1.97B | - | 54 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$10.49
|
$1.92B | - | 51 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$83.45
|
$1.92B | - | 39 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$66.74
|
$1.90B | 49.2 | 70 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$35.05
|
$1.84B | - | 33 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.60
|
$1.81B | - | 33 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$10.89
|
$1.78B | - | 41 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$18.21
|
$1.78B | - | 45 | Compare |
More NBTX Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry